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Ovine scrapie can be transmitted via environmental reservoirs. A pool of ovine scrapie isolates were incubated on
soil for one day or thirteen months and eluted prion was used to challenge tg338 mice transgenic for ovine PrP.
After one-day incubation on soil, two PrPSc phenotypes were present: G338 or Apl338ii. Thirteen months later some
divergent PrPSc phenotypes were seen: a mixture of Apl338ii with either G338 or P338, and a completely novel PrP
Sc
deposition, designated Cag338. The data show that prolonged ageing of scrapie prions within an environmental
matrix may result in changes in the dominant PrPSc biological/biochemical properties.Introduction, methods and results
Prion diseases (or transmissible spongiform encephalop-
athies, TSEs) are fatal, progressive neurological disorders
that have no effective treatment or cure. Prion diseases
include human Creutzfeldt-Jakob disease (CJD), bovine
spongiform encephalopathy (BSE), scrapie in sheep and
goats, and chronic wasting disease (CWD) in deer and
elk. The prion hypothesis states that the causal agent is
a misfolded version of the cellular prion protein (PrPC),
termed PrPSc [1].
It is known that particular prion diseases can include
strains that display distinct and reproducible disease
phenotypes. It is most likely that the prion agent is not a
single entity but is made up of a plethora of different
conformers of PrPSc and the dominant PrPSc confor-
mation causes the specific disease characteristics for a
particular infection including pathology, clinical signs
and PrPSc molecular signatures [2]. The identification of
prion strains is in fact therefore a description of the
dominant disease characteristics. The “gold standard”
method employed to define scrapie strains is mouse bio-
assay using either wild type or preferably transgenic
mice such as the tg338 line [3]. These transgenic mice* Correspondence: kevin.gough@nottingham.ac.uk
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unless otherwise stated.overexpress an ovine PrP transgene and display high
sensitivity and specificity to ovine scrapie prions. Of the
several phenotypic parameters exhibited in a host spe-
cies which are used to discriminate TSEs, PrPSc distribu-
tion in the brain detected by immunohistochemistry
(IHC) or PET/Histo-blot offers the highest discrimi-
natory power and it can be applied on an individual
mouse basis [4-8]. This biological property of prions in
conjunction with analysis of the biochemical properties
of the agent recovered from the same host species offer
a powerful means to identify TSE strains even when they
are applied at primary passage as they remain essentially
unchanged through serial passages [4,6,9,10].
Scrapie is effectively transmitted between susceptible
sheep and goats by animal-to-animal contact and via en-
vironmental reservoirs, a disease trait that is shared with
CWD in deer/elk. For both diseases, the agent is dissem-
inated widely in vivo and excreted/secreted via multiple
routes (reviewed in [11]). The likely location of environ-
mental reservoirs are water, soil, metal surfaces, wood
surfaces and concrete surfaces ([12,13] reviewed in [14]).
Furthermore, environmental prion is stable and remains
infectious for years [15].
The purpose of the present study was to assess the via-
bility of scrapie prions in a soil matrix over time. Pools
of hindbrain from nine scrapie-infected sheep with
VRQ/VRQ (amino acid positions 136, 156 and 171ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Incubation periods of mice after challenge with
scrapie. Mice were inoculated with extracts of soil incubated with a
pool of classical scrapie isolates or with a dilution series of the same
scrapie pool without soil incubation g/mL of brain inoculum are
shown). Open circles: the PrPSc distribution phenotype G338; open
triangles: Apl338ii; square: Cag338; solid triangles: G338/Apl338ii mix;
diamond: P338/Apl338ii mix. Each vertical line indicates the mean
incubation period of a group of mice irrespective of their PrPSc
distribution phenotype. 1D and 13 M are the prion eluted from soil
after a 1 day or 13 month incubation respectively.
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matched scrapie-free controls were made into homoge-
nates and applied to soil columns containing a sandy
loam soil as previously described [16]. Soil columns were
kept at 16–20 °C and constant water content and sam-
pled 1 day and 13 months after the addition of the prion
sample. Equivalent samples were taken for soil incubated
with the prion-free control sample, and soil unexposed
to brain material was used as a further control. All soil
was removed from a column and homogenised by
mixing. Prion protein was then extracted from soil [15]:
100 mg of soil was re-suspended for 1 h in 500 μL PBS
prior to centrifugation at 800 g for 10 min. The soil pel-
let was re-suspended in 100 μL of 1% (w/v) SDS in PBS
and shaken vigorously for 1 h. After centrifugation at
800 g for 10 min prion protein in the supernatant was
removed. Extracted prion was then precipitated for
30 min at 37 °C by the addition of 15 μL of 4% (w/v)
sodium phosphotungstic acid (Napta) and 170 mM mag-
nesium chloride, and recovered by centrifugation at 12
100 g for 30 min. The pellet was air-dried and re-
suspended in 20 μL sterile saline. Each inoculum (20 μL)
was used to challenge intracranially 5–10 week old
tg338 mice (n = 10) as described previously [9]. After in-
oculation the mice were monitored for signs of neuro-
logical disease and were euthanized after exhibiting
clinical signs. All animal work was approved by the
Animal and Plant Health Agency local ethics committee
and was carried out in accordance with the Animals
(Scientific Procedures) Act 1986 under Home Office
project license 70/6310. In combination with clinical
signs, immunohistochemical (IHC) analysis was used to
diagnose prion infection for all mice in the study. After
euthanasia the brain of each mouse was removed and
processed as described previously [9]. TSE diagnosis was
based on PrPSc detection in brain sections with poly-
clonal antibody Rb486 following a standard protocol
[17]. Identification of different PrPSc types and their dis-
tribution in the murine brain was used to identify de-
fined PrPSc distribution patterns as described previously
for wild type and transgenic mice [4-7]. Slides were ana-
lysed blind by two independent observers (J.S. and C.V.);
the agreement between the two observers regarding
PrPSc deposition pattern identification was 100%.
With inoculum extracted from soil incubated with the
scrapie sample for 1 day, eight out of the 10 challenged
mice succumbed to TSE with incubation periods <170 days
post inoculation (dpi) (Figure 1A). IHC analysis of the
mice revealed granular PrPSc deposits distributed mainly
along the brainstem, thalamus and basal ganglia with little
involvement of the cerebral or cerebellar cortex; this pat-
tern has been previously designated as G338 (Figure 2A)
[4]. One further mouse died 483 dpi (Figure 1A) and the
main PrPSc pattern feature was plaques and largeaggregates of PrPSc in the brain parenchyma and peri-
vascular plaques in round meningeal vessels (Figure 2B),
a distribution pattern previously recorded as Apl338ii.
One mouse that died 243 dpi was TSE negative and was
treated as an intercurrent death. No mice displayed
signs of TSE between 170–483 dpi.
After 13 months incubation of the scrapie sample on
soil, prions were extracted and inoculated into tg338 mice.
One mouse was diagnosed TSE negative (intercurrent
death) and the remaining nine were TSE positive. The in-
cubation period of the TSE positive mice was 606–748 dpi
(Figure 1A). With one exception all mice showed a pattern
that was compatible with Apl338ii. This was the only pat-
tern observed in four mice, while in another three it was
observed in conjunction with G338 (Figures 2D-F) and in a
single mouse signs of Apl338ii and P338 were observed con-
comitantly (Figure 2G). P338 is a pattern characterised by
punctate deposits in the neuropil and prominent well-
defined intraneuronal PrPSc accumulations as described
previously [4]. One mouse also showed a previously un-
recognised PrPSc pattern designated Cag338 characterised
by granular PrPSc deposits, which increased in intensity
multifocally, to give rise to coalescing aggregates in the
neuropil (Figure 2C). The areas affected more extensively
were the midbrain and the medulla.
Previous studies have shown that the P338 IHC pre-
sentation of PrPSc is accompanied by a relatively low
Figure 2 Representative images of PrPSc deposition in the midbrain of tg338 mice after challenge with scrapie. The deposition patterns
observed were characteristic of strains G338 (a), Apl338ii (b) and Cag338 (c). Three mice showed phenotypic characteristics typical of both G338 and
Apl338ii patterns; photos d-f are all from a single mouse showing small discrete aggregates (d, red arrow) in the habenular bodies which is a G338
characteristic feature in addition to plaques and large aggregates in subpial areas (d, black arrow; e, periaqueductal grey matter; f, lateral ventricle)
which are associated with Apl338ii. In a single mouse with Apl338ii phenotype, punctate and prominent intraneuronal labelling (g) which are
features associated with the P338 pattern were also observed; the Apl338ii phenotype is not usually associated with intraneuronal labelling (h). The
neurons in g and h are located in the olive nucleus. Scale bar in a-c represents 250 μm; d–f 100 μm; g and h 25 μm.
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both Apl338ii and G338 [4,6]. We looked to investigate
whether the distinct IHC presentations described here
were accompanied by distinct PrPSc properties. Both the
original sheep samples and the murine samples were
digested with PK, analyzed on western blots and the
prion detected with the antibody SHa31 as previously
described [18] (Figures 3A and B). The results show that
all ovine samples had indistinguishable PrPSc profiles
with an unglycosylated PrPSc size of 19.0 +/− 0.3 kDa.
The G338, Apl338ii and G338/Apl338ii mixed IHC pheno-
types had a similar size of 19.1 +/− 0.3 kDa. However,
the Apl338ii/P338 mixed phenotype had a relatively low
molecular mass by comparison of 17.1 kDa, consistent
with previously published data for P338 [4,6]. Also, the
unglycosylated PrPSc of Cag338 had a relatively high mo-
lecular mass of 20.6 kDa (Figure 3B). In addition, we de-
termined that the G338 and Apl338ii IHC phenotypes
could be readily distinguished by the stability of their
PrPSc (Figures 3C and D). The assay was carried out as
described previously [19]. Briefly, aliquots of each mur-
ine brain homogenate were incubated with increasing
molar concentrations of GdnHCl (final concentrations
of 0.5, 2.5, 3.0, 3.5, and 4 M) 1 h at 37 °C. Subsequently
all samples were adjusted to a final GdnHCl concen-
tration of 0.4 M, proteinase K was added to a finalconcentration of 50 μg/mL and the samples incubated
for 1 h at 37 °C. Reactions were stopped with 5 mM
PMSF. Samples were analysed by western blot using
antibody SHa31. The level of signal for each PrP triplet
treated with 2.5, 3.0, 3.5 or 4 M GdnHCl was expressed
as a percentage of the signal for the same sample treated
with 0.5 M. G338 was more susceptible to GdnHCl treat-
ment becoming PK sensitive after treatment with 3 M of
the denaturant. In contrast, Apl338ii was relatively stable
to denaturation with readily detectable PK-resistant
PrPSc after treatment with 4 M GdnHCl (Figures 3C and D).
Overall, the PrPSc biochemical characteristics were distinct
for each of Apl338ii, G338, Apl338ii/P338 mixed and Cag338
IHC phenotypes.
Extracts from soil unexposed to brain material and soil
treated with scrapie-free brain homogenate were bioas-
sayed in tg338 mice and were TSE negative.
For comparison, the original scrapie sample without
any incubation with soil was also titrated in tg338 mice
over a range of 10-fold dilutions (n = 10 mice for each
dilution; Figure 1B). All mice challenged with 20 μg and
2 μg scrapie brain succumbed to scrapie with a G338
IHC phenotype. Only one of the 10 mice challenged
with either 200 or 20 ng of brain pool was diagnosed
with scrapie and in each case this produced an Apl338ii
IHC phenotype. Challenge with lower amounts of brain
a b
c d
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Figure 3 PrPSc characteristics of the scrapie isolates. Nine ovine hindbrain samples that were pooled and incubated with soil (a) were
analysed by western blot. Murine isolates (b) designated G338 (lanes 1, 2 and 3), Apl338ii (lane 4), Apl338ii/G338 mixed phenotype (lane 5), Apl338ii/
P338 mixed phenotype (Lane 6) and Cag338 (Lane 7) are also shown. Blots were probed with anti-PrP antibody SHa31 and molecular mass markers
of 20, 30 and 40 kDa are indicated. All samples were analysed twice to determine the molecular mass of unglycosylated PrPSc and gave consistent
results. The strains G338 (c) and Apl338ii (d) were further analysed by the conformational stability assay and gave distinct profiles. These molecular
traits were consistent both before (closed symbols) and after (open symbols) treatment with SDS and Napta. Analysis was carried out on 3 murine
isolates of G338 and 2 murine isolates of Apl338ii and the presented data is representative of these isolates.
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after 1 day displayed the same IHC and PrPSc pheno-
types as the original scrapie pool, that is Apl338ii and
G338. However, it is possible that the extraction and pre-
cipitation treatments have an effect on PrPSc phenotype
or recovery. To test this, murine brain homogenates for
G338 and Apl338ii phenotypes (10% w/v; 100 μL) were
diluted to 200 μL with 2% (w/v) SDS and shaken vi-
gorously for 1 h. After centrifugation at 800 g for 10 min
prion in the supernatant was precipitated with Napta
and brain homogenate and Napta precipitate were ana-
lyzed by western blot as detailed above and the total sig-
nal for the PrP triplet was determined by densitometry.
The percentage recovery after SDS treatment/Napta pre-
cipitation for each isolate was determined and compari-
son of the recoveries of G338 and Apl338ii was carried
out using a two-tailed students t-test. The percentage
recoveries for 3 isolates of murine G338 and 2 isolates
of murine Apl338ii were determined and the meanTable 1 Main features of characterised strains identified in th
Main PrPSc characteris
Strain Incubation period (IP)* Immunohistochemistr
G338 78 ± 6 Granular deposits mainl
P338 153 ± 8 Punctate and intraneuro
Apl338ii 249 ± 59 Aggregates and plaques
*Incubation period (IP) values denote mean ± SD and indicate days post inoculation
such as Apl338 may be prolonged [6]. G338 is an exceptional strain as shorter IP valu
prolongation by approximately 12 dpi.
♯Western blot values refer to the molecular mass of the unglycosylated band. Abso
P338 unglycosylated band always migrates further indicating a 2 KDa lower moleculrecoveries were 57 and 56% respectively, differences in
the recoveries of the two PrPSc phenotypes were not sig-
nificant (p = 0.97). In addition, the molecular phenotypes
were maintained before and after SDS/Napta treatment
(Figures 3C and D).
Discussion
The bioassay data show that the hit rate was equivalent
for sheep scrapie extracted from soil after 1 day or
13 months incubation indicating ovine scrapie infection
was retained on soil over a prolonged time period. The
data also clearly suggest that between day 1 and month
13 the biological and biochemical properties of the prion
that is desorbed from soil change considerably. In our
view, this concomitant change of biological and bio-
chemical properties as described here is indicative of
strain variation. Indeed many of these phenotypic cha-
racteristics have been attributed to characterised strains
isolated and studied in tg338 mice (Table 1) [4,6]. Someis study [4,6]
tics
y (IHC) Western blot♯
y in brain stem and thalamus 21 KDa
nal deposits mainly in brain stem and thalamus 19 KDa
. Midbrain is most affected area 21 KDa
(dpi) after three serial passages. At first passage IP values of certain strains
es can be observed at primary passage [21] with serial passages resulting in IP
lute values may differ depending on the western blot conditions. However, the
ar mass compared to G338 and Apl338ii.
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cubation are highly novel. Both G338 and P338 strains are
relatively fast incubation strains and have not been re-
ported before in a mixed phenotype with Apl338ii or at
these prolonged incubation times. The identification
particularly of G338 IHC characteristics, in conjunction
with Apl338ii, in the brains of mice showing incubation
period >600 dpi is intriguing as the maximum incubation
period associated with G338 is known to be <200 dpi [20].
Therefore the possibility that G338 was existing as an inde-
pendent entity in the inoculum used to challenge the mice
is unlikely even if we accept that in the presence of a sig-
nificantly slower strain, such as Apl338ii, the propagation
of G338 was delayed. Another possible explanation would
be that agents with G338 or P338 properties could emerge
from Apl338ii at a later stage of the incubation period. Al-
ternatively the G338 and P338 phenotypic characteristics
that were observed in conjunction with Apl338ii indicate
phenotypes that have some G338 or P338 properties associ-
ated with unusually prolonged incubation periods. With-
out isolating each of these agents in a pure state to study
their properties it is not possible to draw definitive conclu-
sions regarding their exact strain characteristics. However,
their existence at this stage, particularly of the P338 IHC
phenotype, which is also accompanied with biochemical
properties that are attributed to the P338 strain, cannot be
ignored and adds valuable information regarding the di-
versity of scrapie phenotypes that can emerge after pro-
longed incubation period with soil. The Cag338 strain
phenotype is reported here for the first time. Collectively,
therefore, these data suggest that the ageing of prions
within an environmental matrix can affect their biological
and biochemical properties suggesting strain alterations.
The three novel phenotypes of desorbed prion strains
observed after 13 months incubation on soil were not de-
tected in a range of 10-fold dilutions of the original scrapie
sample and the SDS/Napta treatment of samples to de-
sorb them from soil had no apparent effect on G338 or
Apl338ii recovery or PrP
Sc phenotype. Therefore, these
novel PrPSc presentations must be a consequence of their
interaction with soil or ageing or both. It is not known
whether this emergence of novel phenotypes seen here
during ageing on soil reflects the selection of existing con-
formers present in the original sample or de novo muta-
tion to produce novel conformations of the prion. The
study compared PrPSc phenotypes that are recovered from
soil after 1 day and 13 month periods and the effects of
soil interaction and incubation time alone are not consi-
dered separately. Therefore it is also not known whether
the observed changes in dominant prion strains are dic-
tated by incubation time at ambient temperature alone or
by interaction with soil over a prolonged period. However,
regardless of the mechanisms of the observed ageing, the
unequivocal finding is that when a mixture of prionphenotypes are added to a soil environment the dominant
pathologies change over time. Whether analogous ageing
of prions occurs in other natural environments that may
harbour prion reservoirs remains to be established. The
presence of “dynamic” reservoirs of environmental scrapie
infectivity could possibly lead to the emergence of novel
strains of scrapie in natural infections. Such events may
have contributed to the significant (and unusual) diversity
of the scrapie disease agent.
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